$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Bangladesh version of neratinib (neratinib) generic drug buying guide
2026-02-01 22:25:32
Check Details
Guide to the efficacy and correct use of giritinib
2026-02-01 22:25:32
Check Details
Detailed explanation of the research and development process, latest market price and purchasing channels of giritinib
2026-02-01 22:25:32
Check Details
Main uses and guidelines for use of giritinib
2026-02-01 22:25:32
Check Details
Molotinib/mometinib wins approval for myelofibrosis
2026-02-01 22:25:32
Check Details
List of Chinese instructions for molotinib/mometinib
2026-02-01 22:25:32
Check Details
How much does a box of molotinib/mometinib cost in 2024?
2026-02-01 22:25:32
Check Details
What is the target of molotinib/mometinib?
2026-02-01 22:25:32
Check Details
The chemical name of molotinib/mometinib
2026-02-01 22:25:32
Check Details
Latest news on molotinib/mometinib
2026-02-01 22:25:32
Check Details
What is the difference between molotinib/mometinib and ruxolitinib tablets?
2026-02-01 22:25:32
Check Details
Is molotinib/mometinib available on the market in China?
2026-02-01 22:25:32
Check Details
1
2
...
1012
1013
1014
1015
1016
1017
1018
...
10238
10239
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Ganaxolone for CDKL5-Related Seizures: GABA-A Modulation, Not a Cure
2
Daraxonrasib (Rasonque): Chemical Identity and RAS Tri-Complex Mechanism
3
Vosoritide Slowing Effect: Not Always Resistance—Check Dose, Adherence, Epiphyses
4
Ramosetron ODT for IBS-D: Gender-Based Dosing and Treatment Review
5
Tamoxifen and Feeling Older: Managing Hot Flashes, Fatigue, and Skin Changes
6
Acoramidis for ATTR-CM: TTR Stabilizer to Reduce CV Death and Hospitalization
7
Vosoritide Storage and Reconstitution: Refrigerate, 90-Day Room Temp, Use Within 3 Hours
8
FDA Approves Pembrolizumab for TMB-H Solid Tumors: Threshold ≥13 mut/Mb, KEYNOTE-158 Data
9
Capmatinib for METex14 NSCLC: Test First, Monitor Toxicity
10
Vosoritide Side Effects and Pre-Injection Food/Fluid: Injection-Site Reactions, Transient Hypotension
11
Ribociclib Still Allows Recurrence: HR+/HER2- Adjuvant and Advanced Use
12
Pretomanid Mechanism and BPaL Use in Drug-Resistant TB